Clinical trial · Observational
Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients
Optimizing an Intervention to Increase Oral Medication Adherence for Metastatic Breast Cancer Patients
NCT06726889CI-TRIAL-00083997recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Aim of this study is to optimize an adherence increasing intervention designed for metastatic Breast Cancer (BC) patients by applying a full factorial design in order to evaluate the optimal combination of three different intervention components.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Decision Support System (DSS) | Behavioral | — | UNRESOLVED |
| Feedback | Behavioral | — | UNRESOLVED |
| Reminders | Behavioral | — | UNRESOLVED |
| Standard care | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (8)
- label
- Standard Care + DSS + Reminders + Feedback
- description
- Patients will receive educational material through a web-page, personalized reminders and feedback messages by physician
- interventionNames
- Behavioral: Standard care
- Behavioral: Decision Support System (DSS)
- Behavioral: Reminders
- Behavioral: Feedback
- label
- Standard Care + DSS + Reminders
- description
- Patients will receive educational material through a web-page and personalized reminders
- interventionNames
- Behavioral: Standard care
- Behavioral: Decision Support System (DSS)
- Behavioral: Reminders
- label
- Standard Care + DSS + Feedback
- description
- Patients will receive educational material through a web-page and feedback messages by physician
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with a diagnosis of metastatic BC * Patients with a prescription for any OAA (i.e. oral chemotherapy, endocrine therapy, and Cyclin-Dependent Kinase 4/6 Inhibitors) * Age \>18 years old * Patients with a personal smart phone with internet access * Willingness and ability to comply with scheduled visits and other trial procedures * Understanding and speaking Italian language * Written informed consent Exclusion Criteria: * Psychiatric disorders or conditions that might impair the ability to give informed consent * Comorbidity that may impact on compliance to study procedures
References
Publications (0)
Data not yet available
No reference posted for this study.